Before Dr. Joshua Sharfstein exited the Food and Drug Administration (FDA) as its principal deputy commissioner, he delivered a speech to industry's top executives and decision-makers gathered in Austin, Texas for the Council for Responsible Nutrition's (CRN) annual retreat. Dr. Sharfstein began with the following slide: “Over the past several years, FDA has found hundreds of products marketed as dietary supplements or conventional foods with hidden drugs and chemicals. The highest risk categories include products promoted for weight loss, sexual enhancement and bodybuilding.”
In reporting this issue, which covers two of these three high-risk...
Sign in to view
the full article
This article is part of our paid subscription packages. You need to subscribe (and sign in) to gain access to this Subscriber Only Content.
Why Subscribe to Nutrition Business Journal?
- In-depth perspective on the $226 billion global nutrition industry
- Receive monthly issues and access up to 5 years of back issues
- Downloadable data files, presentations, and more